Membership Home Portfolio Stocks Bonds Funds ETFs CEFs Markets Tools Real Life Finance Discuss
Home>Topics>>Savient Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript

Savient Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript

Healthcare Sector and Stocks Analysis from Seeking Alpha

Wed, 8 Aug 2012

Savient Pharmaceuticals, Inc. ( SVNT ) Q2 2012 Earnings Call August 08, 2012 09:00 a.m. ET Executives Louis Ferrari – President and Chief Executive Officer Richard Crowley – EVP, Biopharmaceutical Operations Philip Yachmetz – SVP, General Counsel Kenneth Bahrt – SVP, Chief Medical Officer David ...

Read the rest of this article on Healthcare Sector and Stocks Analysis from Seeking Alpha

Content Partners
Site Directory Site Map Our Products
Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News
International Sites: Australia Canada China France Germany Hong Kong Italy The Netherlands Norway Spain U.K. Switzerland India Finland
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.